https://www.selleckchem.com/pr....oducts/ceftaroline-f
Remarkably, ponesimod prevented cuprizone-induced demyelination selectively in the cingulum, but not in the corpus callosum. These data support the CNS activities of ponesimod through S1P1 , including protective, and likely selective, effects against demyelination in a major connection pathway of the brain, the limbic fibers of the cingulum, lesions of which have been associated with several neurologic impairments including MS fatigue. Existing evidence supports superior treatment outcomes in guided bone regeneration (GBR) p